Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	May 01, 2021	May 02, 2020
Cash flows from operating activities:
Net income (loss)	$ 8,697	$ (41,726)
Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities:
Amortization of deferred debt issuance costs	215	35
Impairment of assets	(652)	16,335
Depreciation and amortization	4,500	5,732
Stock compensation expense	327	452
Board of directors stock compensation	109	149
Changes in operating assets and liabilities:
Accounts receivable	1,745	4,281
Inventories	(3,362)	(5,905)
Prepaid expenses and other current assets	(2,692)	5,920
Other assets	4	606
Accounts payable	4,548	98
Operating leases, net	(6,318)	(1,327)
Accrued expenses and other liabilities	644	(1,461)
Net cash provided by (used for) operating activities	7,765	(16,811)
Cash flows from investing activities:
Additions to property and equipment, net	(803)	(1,590)
Net cash used for investing activities	(803)	(1,590)
Cash flows from financing activities:
Proceeds from issuance of common stock from private direct offering, net of offering costs	4,375
Net borrowings (repayments) under credit facility	(26,173)	40,214
Debt issuance costs	(818)	(4)
Net cash provided by (used for) financing activities	(20,116)	40,210
Net increase (decrease) in cash and cash equivalents	(13,154)	21,809
Cash and cash equivalents:
Beginning of period	18,997	4,338
End of period	5,843	$ 26,147
FILO Loan
Cash flows from financing activities:
Repayment of existing FILO loan	(15,000)
Proceeds from new FILO loan	$ 17,500